While some cancers and metabolic diseases are characterized by PERK hyperactivation, genetic ablation of PERK results in glucose dysregulation and pancreatitis, suggesting that some basal level of PERK activity is essential to pancreatic health [15,16]. Here, EIF2AK3 is linked to cancer.